bluebird bio (NASDAQ:BLUE) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com initiated coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a research report issued on Tuesday. The brokerage set a “sell” rating on the biotechnology company’s stock. Other research analysts also recently issued research reports about the stock. Barclays cut their target price on shares of bluebird bio […]
Investment analysts at StockNews.com initiated coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a research report issued on Tuesday. The brokerage set a “sell” rating on the biotechnology company’s stock. Other research analysts also recently issued research reports about the stock. Barclays cut their target price on shares of bluebird bio […]
